254 related articles for article (PubMed ID: 9751121)
1. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis.
Sebastian J; Richards RG; Walker MP; Wiesen JF; Werb Z; Derynck R; Hom YK; Cunha GR; DiAugustine RP
Cell Growth Differ; 1998 Sep; 9(9):777-85. PubMed ID: 9751121
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression.
Gillgrass A; Cardiff RD; Sharan N; Kannan S; Muller WJ
Oncogene; 2003 Dec; 22(57):9151-5. PubMed ID: 14668796
[TBL] [Abstract][Full Text] [Related]
3. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
4. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
5. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
6. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
Ram TG; Hosick HL; Ethier SP
J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
[TBL] [Abstract][Full Text] [Related]
7. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland.
Schroeder JA; Lee DC
Cell Growth Differ; 1998 Jun; 9(6):451-64. PubMed ID: 9663464
[TBL] [Abstract][Full Text] [Related]
8. Ductal growth is impeded in mammary glands of C-neu transgenic mice.
Mukherjee S; Louie SG; Campbell M; Esserman L; Shyamala G
Oncogene; 2000 Dec; 19(52):5982-7. PubMed ID: 11146549
[TBL] [Abstract][Full Text] [Related]
9. The mouse mammary gland requires the actin-binding protein gelsolin for proper ductal morphogenesis.
Crowley MR; Head KL; Kwiatkowski DJ; Asch HL; Asch BB
Dev Biol; 2000 Sep; 225(2):407-23. PubMed ID: 10985859
[TBL] [Abstract][Full Text] [Related]
10. EGF receptor regulation in normal mouse mammary gland.
Haslam SZ; Counterman LJ; Nummy KA
J Cell Physiol; 1992 Sep; 152(3):553-7. PubMed ID: 1506414
[TBL] [Abstract][Full Text] [Related]
11. Mammary gland development in transforming growth factor beta1 null mutant mice: systemic and epithelial effects.
Ingman WV; Robertson SA
Biol Reprod; 2008 Oct; 79(4):711-7. PubMed ID: 18614704
[TBL] [Abstract][Full Text] [Related]
12. SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice.
Li H; Rajendran GK; Liu N; Ware C; Rubin BP; Gu Y
Breast Cancer Res; 2007; 9(1):R1. PubMed ID: 17201918
[TBL] [Abstract][Full Text] [Related]
13. Developmental response of adult mammary epithelial cells to various fetal and neonatal mesenchymes.
Cunha GR; Young P; Hamamoto S; Guzman R; Nandi S
Epithelial Cell Biol; 1992 Jul; 1(3):105-18. PubMed ID: 1307943
[TBL] [Abstract][Full Text] [Related]
14. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development.
Wiesen JF; Young P; Werb Z; Cunha GR
Development; 1999 Jan; 126(2):335-44. PubMed ID: 9847247
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
16. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG
Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255
[TBL] [Abstract][Full Text] [Related]
17. Control of the three-dimensional growth pattern of mammary epithelium: role of genes of the Wnt and erbB families studied using reconstituted epithelium.
Edwards PA
Biochem Soc Symp; 1998; 63():21-34. PubMed ID: 9513708
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous consequences of inhibiting EGF receptor signaling in vivo: normal hair follicle development, but retarded hair cycle induction and inhibition of adipocyte growth in Egfr(Wa5) mice.
Sugawara K; Schneider MR; Dahlhoff M; Kloepper JE; Paus R
J Dermatol Sci; 2010 Mar; 57(3):155-61. PubMed ID: 20060271
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth.
Andrechek ER; White D; Muller WJ
Oncogene; 2005 Jan; 24(5):932-7. PubMed ID: 15580295
[TBL] [Abstract][Full Text] [Related]
20. Effects of epidermal growth factor, estrogen, and progestin on DNA synthesis in mammary cells in vivo are determined by the developmental state of the gland.
Haslam SZ; Counterman LJ; Nummy KA
J Cell Physiol; 1993 Apr; 155(1):72-8. PubMed ID: 8468371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
